Published 1 day ago • loading... • Updated 11 hours ago

Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on notice

The US Food and Drug Administration announced that semaglutide is no longer in shortage, impacting compounded versions of the drug.
Ozempic and Wegovy had been on the FDA's shortage list since March 2022 due to high demand, which greatly increased Novo Nordisk's market value.
The FDA set deadlines for 503A and 503B compounding pharmacies to stop producing compounded versions of the drugs, with April 22 and May 22 as final dates respectively.
While supply is improving, patients may still face disruptions as medications transition from manufacturing to pharmacies.

Insights by Ground AI

Does this summary seem wrong?

49 Articles

All

Left

Center

Right

WLKY

+7 Reposted by 7 other sources

Shortage of popular weight-loss, diabetes drugs is resolved, FDA says

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity treatments continue to improve.

11 hours ago·Louisville, United States

Read Full Article

Origo

Ozempic is a hit, pharmaceutical sales account for half of Denmark's GDP

Two years ago, Danish company Novo Nordisk was barely known, but today the company's market value has skyrocketed, thanks to the outstanding sales of the drugs Wegovy and Ozempic. Sales of anti-obesity and diabetes drugs have grown tremendously, making the company one of the most valuable companies in Europe.

13 hours ago·Budapest, Hungary

Read Full Article

MedPage Today

Ozempic, Wegovy Shortage Is Officially Over

(MedPage Today) -- The shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday. The agency, along with maker Novo Nordisk, confirmed that supply now meets or exceeds both the current and projected U.S. demand...

15 hours ago·New York, United States

Read Full Article

MarketWatch

FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.

“We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.

15 hours ago·United States

Read Full Article

CNN

+3 Reposted by 3 other sources

Ozempic and Wegovy are no longer in shortage, FDA says

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

15 hours ago·Atlanta, United States

Read Full Article

Toronto Sun

Yearslong shortage of Ozempic and Wegovy in U.S. resolved, FDA says

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the popular diabetes and obesity treatments continue to improve, federal regulators said Friday.

16 hours ago·Toronto, Canada

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year